Stock NGEN NERVGEN PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Market Closed - Toronto S.E.
Other stock markets
 03:59:59 2024-04-24 pm EDT 		5-day change 1st Jan Change
2.09 CAD +1.46% Intraday chart for NervGen Pharma Corp. +3.47% -22.59%
Apr. 17 NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update MT
Apr. 17 NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on NervGen Pharma Corp.

Price target over the last 5 years

History of analyst recommendation changes

41bbb1a7e.iNI67S8teh65TdH_KUfZtCkfNXasY5PUC8I279bG5jo.zZxuu3UeT2fqLJKseCyo63ZWBxzfJKScT5QFupiSy1nS4Hi_WFsddOgaiA~ddd0573f1e43931bb56533bede22a9bd

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.06 CAD
Average target price
5 CAD
Spread / Average Target
+142.72%
High Price Target
5 CAD
Spread / Highest target
+142.72%
Low Price Target
5 CAD
Spread / Lowest Target
+142.72%

Consensus detail

Consensus revision (last 18 months)

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NGEN Stock
  4. Consensus NervGen Pharma Corp.